Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Trial in p16-Positive, Non-Smoking Associated Locoregionally Advanced Oropharyngeal Cancer
2016-002244-16Phase 2Terminated
- Sponsor
- Cancer Trials Ireland
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cisplatin in oropharyngeal cancer, sponsored by Cancer Trials Ireland. Primary endpoint: Progression-free survival at 2 years. Started Jul 2016; status: terminated.
02
Drugs
cisplatin
03
Conditions
oropharyngeal cancer
Beyond the preview
Go deeper on 2016-002244-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002244-16.